MoonLake Immunotherapeutics
MLTX
MLTX
46 hedge funds and large institutions have $122M invested in MoonLake Immunotherapeutics in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+46
Holders Change %
–
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
46
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
+$11.5M |
2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.53M |
3 |
BlackRock
New York
|
+$8.53M |
4 |
RI
RTW Investments
New York
|
+$8.53M |
5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$7.96M |
Top Sellers
No sellers this quarter